Linden Advisors LP purchased a new position in GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The fund purchased 797,584 shares of the company’s stock, valued at approximately $8,454,000.
A number of other hedge funds have also recently bought and sold shares of the business. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in GP-Act III Acquisition during the 2nd quarter worth approximately $2,638,000. Meteora Capital LLC bought a new stake in shares of GP-Act III Acquisition in the 2nd quarter worth about $20,330,000. Radcliffe Capital Management L.P. lifted its position in shares of GP-Act III Acquisition by 287.8% during the third quarter. Radcliffe Capital Management L.P. now owns 572,895 shares of the company’s stock worth $6,073,000 after purchasing an additional 425,152 shares during the last quarter. Wolverine Asset Management LLC increased its holdings in GP-Act III Acquisition by 90.6% in the third quarter. Wolverine Asset Management LLC now owns 954,866 shares of the company’s stock valued at $10,122,000 after buying an additional 453,866 shares during the last quarter. Finally, Clear Street LLC increased its holdings in GP-Act III Acquisition by 8,429.8% in the second quarter. Clear Street LLC now owns 10,321 shares of the company’s stock valued at $109,000 after buying an additional 10,200 shares during the last quarter.
GP-Act III Acquisition Stock Up 0.1%
NASDAQ GPAT opened at $10.79 on Tuesday. GP-Act III Acquisition Corp. has a one year low of $10.27 and a one year high of $10.80. The company has a 50-day simple moving average of $10.75 and a 200-day simple moving average of $10.68.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on GPAT
About GP-Act III Acquisition
GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.
Featured Stories
- Five stocks we like better than GP-Act III Acquisition
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report).
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
